Sen. Tommy Tuberville bought State Street SPDR S&P Biotech ETF (XBI)
Sen. Tommy Tuberville (R-AL) · $1K–$15K · traded May 8, 2024
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Joint
- Traded
- May 8, 2024
- Disclosed
- Aug 5, 2026
- Days to disclose
- 819 (after the 45-day deadline)
- Asset type
- Stock Option
- As filed
- SPDR S&P Biotech ETF
- Industry
- Asset Management · Financial Services
Other trades in this filing
All of Tuberville's trades →- Aug 5, 2026$100K–$250K
$100K–$250K · Traded May 13, 2024 · disclosed Aug 5, 2026 · Joint · filed 814 days later
- Aug 5, 2026$100K–$250K
$100K–$250K · Traded May 13, 2024 · disclosed Aug 5, 2026 · Joint · filed 814 days later
- Aug 5, 2026$50K–$100K
$50K–$100K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$100K–$250K
$100K–$250K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$1K–$15K
$1K–$15K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$1K–$15K
$1K–$15K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$1K–$15K
$1K–$15K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$1K–$15K
$1K–$15K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$1K–$15K
Bought ARK Innovation ETF ARKK
$1K–$15K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$1K–$15K
$1K–$15K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$50K–$100K
$50K–$100K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$15K–$50K
$15K–$50K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$1K–$15K
$1K–$15K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$1K–$15K
$1K–$15K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$1K–$15K
$1K–$15K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$1K–$15K
$1K–$15K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$100K–$250K
$100K–$250K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$1K–$15K
$1K–$15K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$50K–$100K
$50K–$100K · Traded May 10, 2024 · disclosed Aug 5, 2026 · Joint · filed 817 days later
- Aug 5, 2026$1K–$15K
Bought State Street SPDR S&P Biotech ETF XBI
$1K–$15K · Traded May 8, 2024 · disclosed Aug 5, 2026 · Joint · filed 819 days later
Recent Congress trades in XBI
- Aug 5, 2026$1K–$15K
Sen. Tommy Tuberville (R-AL)
Bought State Street SPDR S&P Biotech ETF XBI
$1K–$15K · Traded May 8, 2024 · disclosed Aug 5, 2026 · Joint · filed 819 days later
- Aug 5, 2026$1K–$15K
Sen. Tommy Tuberville (R-AL)
Bought State Street SPDR S&P Biotech ETF XBI
$1K–$15K · Traded May 8, 2024 · disclosed Aug 5, 2026 · Joint · filed 819 days later
- Jun 14, 2024$1K–$15K
Sen. Tommy Tuberville (R-AL)
Bought State Street SPDR S&P Biotech ETF XBI
$1K–$15K · Traded May 8, 2024 · disclosed Jun 14, 2024 · Joint
- Oct 18, 2019$15K–$50K
Sen. James M. Inhofe (R-OK)
Sold (full) State Street SPDR S&P Biotech ETF XBI
$15K–$50K · Traded Sep 30, 2019 · disclosed Oct 18, 2019
- Jan 9, 2019$15K–$50K
Sen. James M. Inhofe (R-OK)
Bought State Street SPDR S&P Biotech ETF XBI
$15K–$50K · Traded Dec 31, 2018 · disclosed Jan 9, 2019
- Mar 12, 2018$1K–$15K
Sen. Jack Reed (D-RI)
Sold (partial) State Street SPDR S&P Biotech ETF XBI
$1K–$15K · Traded Mar 9, 2018 · disclosed Mar 12, 2018 · Joint
- Jun 20, 2017$1K–$15K
Sen. Jack Reed (D-RI)
Bought State Street SPDR S&P Biotech ETF XBI
$1K–$15K · Traded Jun 19, 2017 · disclosed Jun 20, 2017 · Joint
- Mar 7, 2017$1K–$15K
Sen. Jack Reed (D-RI)
Bought State Street SPDR S&P Biotech ETF XBI
$1K–$15K · Traded Mar 6, 2017 · disclosed Mar 7, 2017
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.